March 30, 2013, Hyderabad, India –3rd Annual Vaccine World Summit 2013 is being held in “The Westin Hotel” Pune, India on 5th to 7thMarch, 2013.
The Conference is organized and managed by IMPAC Pte. LTD. Over 30 World-Class speakers will be present share their experiences and knowledge at this event.
A number of informative sessions followed the opening remarks by Chairman Dr. Harish Iyer, CEO of Shantha Biotechnics Ltd., on 5thMarch,2013. In brief, this included four panel discussions, two case studies and three interactive roundtable discussions surrounded nine different vaccines including typhoid fever, and Salmonelelloses, Streptococcus pneumonia vaccine, 9-Valent HPV Vaccine, TB Vaccine, RSV, Malaria Vaccine, HIV Vaccine, Dengue Vaccine and more. The expert, distinguished brought to the fore various challenges surrounding of some vaccine.
The conference focus on the latest success strategies for vaccines in India and the rest of the world, innovative manufacturing technologies, research funding and novel vaccines.
The goals of the conference are to increase the availability of life saving vaccines, decrease the cost of these vaccines and work together to find a cure for current and emerging diseases that continue to pose a threat to our health, welfare and happiness.
The vaccine Outstanding Achievements awards to recognize advancements in the field of vaccine manufacturing and will hand out awards to the winners of the five award Categories : Best Industrial Partnership in India, Most promising Vaccine for emerging diseases in India, Most Promising vaccine for Pediatric Disease in India, Best Vaccine Pipeline in India and life time Achievement award.
The Vaccine World Summit 2013 is sponsored by World leaders in Vaccine technology viz. General Health Care, Merck Millipore and NNE Pharmaplan. It’s partner include DCVMN (Developing Countries Vaccine Manufacturers Network) and Media partners like Bio Pharm insight, Pharma China, Asia Pacific Biotech, Human Vaccines and Immunotherapeutics, Pharma Voice, DNA Vaccine and Pharma Asia. etc.
No comments:
Post a Comment